Flat Footed LLC Grifols Sa Transaction History

Flat Footed LLC

$451 Million
Q1 2024

A detailed history of Flat Footed LLC transactions in Grifols Sa stock. As of the latest transaction made, Flat Footed LLC holds 7,036,880 shares of GRFS stock, worth $44.3 Million. This represents 10.42% of its overall portfolio holdings.

Number of Shares

7,036,880

Previous 7,358,779 4.37%

Holding current value

$44.3 Million

Previous $85.1 Million 44.74%

% of portfolio

10.42%

Previous 9.54%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$5.47 - $11.38 $1.76 Million - $3.66 Million	-321,899 Reduced 4.37%	7,036,880 $47 Million
Q4 2023 Feb 14, 2024	SELL	$7.71 - $11.56 $15 Million - $22.4 Million	-1,941,520 Reduced 20.88%	7,358,779 $85.1 Million
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $9.35 Million - $11.4 Million	1,049,155 Added 12.72%	9,300,299 $85 Million
Q2 2023 Aug 14, 2023	SELL	$7.14 - $9.29 $2.94 Million - $3.83 Million	-412,104 Reduced 4.76%	8,251,144 $75.6 Million
Q1 2023 May 15, 2023	BUY	$6.65 - $10.69 $4.82 Million - $7.75 Million	724,514 Added 9.13%	8,663,248 $63.8 Million

Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $13.9 Million - $19.9 Million	2,338,553 Added 41.76%	7,938,734 $67.5 Million
Q3 2022 Nov 14, 2022	BUY	$5.95 - $14.3 $27.7 Million - $66.7 Million	4,662,971 Added 497.54%	5,600,181 $34.5 Million
Q2 2022 Aug 15, 2022	SELL	$10.6 - $13.28 $1.11 Million - $1.39 Million	-104,504 Reduced 10.03%	937,210 $11.1 Million
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $1.19 Million - $1.46 Million	-114,447 Reduced 9.9%	1,041,714 $12.2 Million
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $11.8 Million - $17.7 Million	1,156,161 New	1,156,161 $13 Million

Others Institutions Holding GRFS

# of Institutions

150

Shares Held

140M

Call Options Held

3.54M

Put Options Held

919K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.28B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Flat Footed LLC, based on Form 13F filings with the SEC.

News

Stay updated on Flat Footed LLC with notifications on news.

Account